Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Gilead Sciences Inc | 11 | 0 | 1 | 0 | €71.02 | €85.74 | 20.722% |
| Medtronic plc | 8 | 1 | 3 | 0 | €81.10 | €94.50 | 16.523% |
| BioMarin Pharmaceutical Inc. | 26 | 0 | 6 | 0 | €75.84 | €102.62 | 35.310% |
| Ipsen S.A. | 1 | 0 | 0 | 0 | €107.80 | €109.00 | 1.113% |
| Sanofi S.A. | 4 | 0 | 0 | 0 | €104.32 | €109.00 | 4.486% |
| Novartis AG ADR | 3 | 0 | 0 | 0 | €105.50 | €112.40 | 6.538% |
| Abbott Laboratories | 20 | 0 | 2 | 0 | €102.78 | €116.25 | 13.103% |
| Dexcom Inc. | 26 | 0 | 2 | 0 | €61.88 | €121.12 | 95.739% |
| Merck & Co. Inc. | 31 | 1 | 1 | 0 | €106.40 | €125.78 | 18.214% |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €116.30 | €130.00 | 11.780% |
| Agilent Technologies Inc. | 16 | 5 | 3 | 1 | €123.74 | €134.50 | 8.697% |
| Quest Diagnostics Inc. | 7 | 0 | 0 | 0 | €137.95 | €145.02 | 5.124% |
| Novo Nordisk A/S ADR | 24 | 1 | 4 | 0 | €118.50 | €145.75 | 22.996% |
| Illumina Inc. | 32 | 4 | 8 | 0 | €112.16 | €160.20 | 42.833% |
| AstraZeneca plc | 2 | 0 | 0 | 0 | €149.55 | €165.00 | 10.331% |
| Merck KGaA | 5 | 1 | 1 | 0 | €168.35 | €172.00 | 2.168% |
| AbbVie Inc. | 34 | 0 | 2 | 0 | €174.48 | €180.90 | 3.681% |
| Universal Health Services B | 15 | 6 | 2 | 0 | €208.00 | €190.70 | -8.318% |
| Johnson & Johnson | 39 | 1 | 1 | 0 | €148.28 | €194.53 | 31.192% |
| Novo Nordisk A/S | 5 | 0 | 1 | 0 | €185.00 | €195.00 | 5.405% |
| Zoetis Inc. A | 23 | 1 | 3 | 0 | €170.66 | €196.17 | 14.946% |
| Resmed Inc. | 20 | 0 | 0 | 0 | €220.80 | €216.62 | -1.891% |
| EssilorLuxottica SA | 3 | 0 | 1 | 0 | €208.40 | €224.50 | 7.726% |
| Laboratory Corp. Of America (labcorp) | 15 | 0 | 0 | 0 | €197.00 | €239.41 | 21.527% |
| Teleflex Inc. | 11 | 0 | 0 | 0 | €216.00 | €245.97 | 13.873% |